Revisions of 'Diffuse midline glioma, H3 K27-altered'
-
Revision 17 - created 23 days ago by Frank Gaillard - view changesetDate: 2024-04-13 12:37:54 UTC Disclosures:
At the time the revision was created Frank Gaillard had no financial relationships to ineligible companies to disclose.
View Frank Gaillard's current disclosures Reviewed by: Hoe Han Guan -
Revision 16 - created 26 days ago by Mohammad Sattouf - view changesetDate: 2024-04-10 02:28:43 UTC Disclosures:
At the time the revision was created Mohammad Sattouf had no financial relationships to ineligible companies to disclose.
View Mohammad Sattouf's current disclosures Reviewed by: Frank Gaillard -
Revision 15 - created 27 days ago by Mohammad Sattouf - view changesetDate: 2024-04-09 02:10:26 UTC Disclosures:
At the time the revision was created Mohammad Sattouf had no financial relationships to ineligible companies to disclose.
View Mohammad Sattouf's current disclosures Reviewed by: Frank Gaillard -
Revision 14 - created about 1 month ago by Rohit Sharma - view changesetDate: 2024-03-29 10:03:51 UTC Disclosures:
At the time the revision was created Rohit Sharma had no financial relationships to ineligible companies to disclose.
View Rohit Sharma's current disclosures Reviewed by: Joachim Feger -
Revision 13 - created 5 months ago by Keshaw Kumar - view changesetDate: 2023-12-12 16:23:34 UTC Disclosures:
At the time the revision was created Keshaw Kumar had no financial relationships to ineligible companies to disclose.
View Keshaw Kumar's current disclosures Reviewed by: Hoe Han Guan -
Revision 12 - created 7 months ago by Michael P Hartung - view changesetDate: 2023-09-26 14:13:39 UTC Disclosures:
At the time the revision was created Michael P Hartung had the following disclosures:
- Otsuka Pharmaceutical, Consultant (past)
- Innovenn, Inc, Consultant (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Michael P Hartung's current disclosures Reviewed by: Rohit Sharma -
Revision 11 - created over 1 year ago by Joshua Yap - view changesetDate: 2022-10-13 03:09:40 UTC Disclosures:
At the time the revision was created Joshua Yap had no financial relationships to ineligible companies to disclose.
View Joshua Yap's current disclosures Reviewed by: Mohammad Taghi Niknejad -
Revision 10 - created over 1 year ago by Frank Gaillard - view changesetDate: 2022-10-11 22:35:42 UTC Disclosures:
At the time the revision was created Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures Reviewed by: Rohit Sharma -
Revision 9 - created over 1 year ago by Francis Deng - view changesetDate: 2022-09-08 16:43:13 UTC Disclosures:
At the time the revision was created Francis Deng had no financial relationships to ineligible companies to disclose.
View Francis Deng's current disclosures Reviewed by: Henry Knipe -
Revision 8 - created about 2 years ago by Frank Gaillard - view changesetDate: 2022-04-06 04:19:14 UTC Disclosures:
At the time the revision was created Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd, Founder and CEO (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software development in multiple sclerosis (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures Reviewed by: Joachim Feger -
Revision 7 - created about 2 years ago by Frank Gaillard - view changesetDate: 2022-04-06 02:45:35 UTC Disclosures:
At the time the revision was created Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd, Founder and CEO (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software development in multiple sclerosis (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures Reviewed by: Joachim Feger -
Revision 6 - created over 2 years ago by Frank Gaillard - view changesetDate: 2021-10-18 23:21:42 UTC Disclosures:
At the time the revision was created Frank Gaillard had no recorded disclosures.
View Frank Gaillard's current disclosures Reviewed by: Yuranga Weerakkody -
Revision 5 - created almost 3 years ago by Patrick J Rock - view changesetDate: 2021-05-22 03:26:55 UTC Disclosures:
At the time the revision was created Patrick J Rock had no recorded disclosures.
View Patrick J Rock's current disclosures Reviewed by: Joachim Feger -
Revision 4 - created over 4 years ago by Bálint Botz - view changesetDate: 2019-12-31 16:33:58 UTC Disclosures:
At the time the revision was created Bálint Botz had no recorded disclosures.
View Bálint Botz's current disclosures Reviewed by: Tee Yu Jin -
Revision 3 - created about 7 years ago by Frank Gaillard - view changesetDate: 2017-04-24 01:31:24 UTC Disclosures:
At the time the revision was created Frank Gaillard had no recorded disclosures.
View Frank Gaillard's current disclosures Reviewed by: Yuranga Weerakkody -
Revision 2 - created about 7 years ago by Frank Gaillard - view changesetDate: 2017-04-10 02:25:59 UTC Disclosures:
At the time the revision was created Frank Gaillard had no recorded disclosures.
View Frank Gaillard's current disclosures Reviewed by: Owen Kang -
Revision 1 - created almost 8 years ago by Frank Gaillard - view changesetDate: 2016-06-18 03:45:57 UTC Disclosures:
At the time the revision was created Frank Gaillard had no recorded disclosures.
View Frank Gaillard's current disclosures Reviewed by: Frank Gaillard
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.